Albiglutide
A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment.
GSK · Phase 3 · Completed · Enrollment 507
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.